Search

Jean P. Cornet

Examiner (ID: 12155, Phone: (571)270-7669 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1628, 1614
Total Applications
1472
Issued Applications
565
Pending Applications
145
Abandoned Applications
815

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18451392 [patent_doc_number] => 20230192670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => ACID ADDITION SALTS OF BENZIMIDAZOLE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/990806 [patent_app_country] => US [patent_app_date] => 2022-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6055 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17990806 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/990806
Acid addition salts of benzimidazole derivative Nov 20, 2022 Issued
Array ( [id] => 18503565 [patent_doc_number] => 11701355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-18 [patent_title] => Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) [patent_app_type] => utility [patent_app_number] => 18/057116 [patent_app_country] => US [patent_app_date] => 2022-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 44 [patent_no_of_words] => 26500 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057116 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/057116
Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) Nov 17, 2022 Issued
Array ( [id] => 18295177 [patent_doc_number] => 20230104863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING 3,3'-DIINDOLYLMETHANE [patent_app_type] => utility [patent_app_number] => 18/054111 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28066 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054111 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/054111
Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane Nov 8, 2022 Issued
Array ( [id] => 18281384 [patent_doc_number] => 20230096856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => COMBINED TREATMENT REGIMEN OF ANESTHESIA/SEDATION WITH ADMINISTRATION OF PSYCHEDELIC DRUGS ASSOCIATED WITH REDUCTION IN NEUROPSYCHIATRIC ILLNESS [patent_app_type] => utility [patent_app_number] => 17/935839 [patent_app_country] => US [patent_app_date] => 2022-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935839 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/935839
COMBINED TREATMENT REGIMEN OF ANESTHESIA/SEDATION WITH ADMINISTRATION OF PSYCHEDELIC DRUGS ASSOCIATED WITH REDUCTION IN NEUROPSYCHIATRIC ILLNESS Sep 26, 2022 Abandoned
Array ( [id] => 18251867 [patent_doc_number] => 20230078906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => SUSTAINED RELEASE DEXAMETHASONE FORMULATION [patent_app_type] => utility [patent_app_number] => 17/948842 [patent_app_country] => US [patent_app_date] => 2022-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948842 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/948842
SUSTAINED RELEASE DEXAMETHASONE FORMULATION Sep 19, 2022 Abandoned
Array ( [id] => 18222140 [patent_doc_number] => 20230061134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => METHODS AND COMPOSITIONS FOR STIMULATION AND ENHANCEMENT OF REGENERATION OF TISSUES [patent_app_type] => utility [patent_app_number] => 17/933598 [patent_app_country] => US [patent_app_date] => 2022-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12361 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933598 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/933598
METHODS AND COMPOSITIONS FOR STIMULATION AND ENHANCEMENT OF REGENERATION OF TISSUES Sep 19, 2022 Pending
Array ( [id] => 18962828 [patent_doc_number] => 11896567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Combination composition [patent_app_type] => utility [patent_app_number] => 17/943708 [patent_app_country] => US [patent_app_date] => 2022-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1695 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943708 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/943708
Combination composition Sep 12, 2022 Issued
Array ( [id] => 18140392 [patent_doc_number] => 20230014231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => METHODS FOR TREATING NEUTROPENIA [patent_app_type] => utility [patent_app_number] => 17/941509 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941509 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941509
Methods for treating neutropenia Sep 8, 2022 Issued
Array ( [id] => 18279816 [patent_doc_number] => 20230095288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => METAL SALTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/821699 [patent_app_country] => US [patent_app_date] => 2022-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821699 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/821699
Metal salts and uses thereof Aug 22, 2022 Issued
Array ( [id] => 19032423 [patent_doc_number] => 20240082238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/890757 [patent_app_country] => US [patent_app_date] => 2022-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890757 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/890757
COMPOSITIONS AND METHODS FOR TREATING CANCER Aug 17, 2022 Pending
Array ( [id] => 18550733 [patent_doc_number] => 20230248733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS [patent_app_type] => utility [patent_app_number] => 17/890130 [patent_app_country] => US [patent_app_date] => 2022-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890130 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/890130
HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS Aug 16, 2022 Pending
Array ( [id] => 18434235 [patent_doc_number] => 20230181529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA [patent_app_type] => utility [patent_app_number] => 17/889029 [patent_app_country] => US [patent_app_date] => 2022-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889029 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/889029
PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA Aug 15, 2022 Abandoned
Array ( [id] => 20039120 [patent_doc_number] => 20250177342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => HYDROXYPENTYL BENZOIC ACID DIESTER COMPOUND, AND PREPARATION METHOD AND PHARMACEUTICAL APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/271036 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271036 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/271036
Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof Aug 14, 2022 Issued
Array ( [id] => 20039120 [patent_doc_number] => 20250177342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => HYDROXYPENTYL BENZOIC ACID DIESTER COMPOUND, AND PREPARATION METHOD AND PHARMACEUTICAL APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/271036 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271036 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/271036
Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof Aug 14, 2022 Issued
Array ( [id] => 20039120 [patent_doc_number] => 20250177342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => HYDROXYPENTYL BENZOIC ACID DIESTER COMPOUND, AND PREPARATION METHOD AND PHARMACEUTICAL APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/271036 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271036 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/271036
Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof Aug 14, 2022 Issued
Array ( [id] => 19947034 [patent_doc_number] => 12318372 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-03 [patent_title] => Formulations with enhanced SN-38 solubility and oral absorption [patent_app_type] => utility [patent_app_number] => 17/882458 [patent_app_country] => US [patent_app_date] => 2022-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 13 [patent_no_of_words] => 4506 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17882458 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/882458
Formulations with enhanced SN-38 solubility and oral absorption Aug 4, 2022 Issued
Array ( [id] => 18034555 [patent_doc_number] => 20220378770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE [patent_app_type] => utility [patent_app_number] => 17/881874 [patent_app_country] => US [patent_app_date] => 2022-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881874 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/881874
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde Aug 4, 2022 Issued
Array ( [id] => 19716101 [patent_doc_number] => 12201616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-21 [patent_title] => Methods and compositions for treatment of mydriasis [patent_app_type] => utility [patent_app_number] => 17/877564 [patent_app_country] => US [patent_app_date] => 2022-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 45186 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877564 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/877564
Methods and compositions for treatment of mydriasis Jul 28, 2022 Issued
Array ( [id] => 19716100 [patent_doc_number] => 12201615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-21 [patent_title] => Methods and compositions for treatment of mydriasis [patent_app_type] => utility [patent_app_number] => 17/877558 [patent_app_country] => US [patent_app_date] => 2022-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 45289 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877558 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/877558
Methods and compositions for treatment of mydriasis Jul 28, 2022 Issued
Array ( [id] => 18034536 [patent_doc_number] => 20220378751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => INHIBITING DIHYDROFOLATE REDUCTASE IN A MICROORGANISM [patent_app_type] => utility [patent_app_number] => 17/870855 [patent_app_country] => US [patent_app_date] => 2022-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17870855 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/870855
INHIBITING DIHYDROFOLATE REDUCTASE IN A MICROORGANISM Jul 21, 2022 Abandoned
Menu